Literature DB >> 11257651

Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer.

C R Riedl1, D Daniltchenko, F Koenig, R Simak, S A Loening, H Pflueger.   

Abstract

PURPOSE: Several investigators have demonstrated an approximately 20% higher tumor detection rate by 5-aminolevulinic acid (ALA) fluorescence endoscopy compared to standard white light cystoscopy, and suggested a reduction in tumor recurrences when fluorescence endoscopy was performed as standard procedure during transurethral resection. We test this hypothesis.
MATERIALS AND METHODS: In a prospective randomized multicenter study 102 patients underwent transurethral resection of bladder tumor(s) either with white light or ALA fluorescence assisted endoscopy. A second look transurethral resection with ALA fluorescence endoscopy was performed 6 weeks after the initial operation.
RESULTS: At second look transurethral resection tumor was detected in 20 of 51 patients (39%) in the white light group and in 8 of 51 (16%) in the ALA fluorescence endoscopy group. This difference was statistically significant (p = 0.005).
CONCLUSIONS: ALA fluorescence endoscopy is an innocuous and inexpensive diagnostic procedure that significantly improves bladder tumor detection rates compared to standard white light endoscopy. In our controlled study ALA fluorescence endoscopy reduced the residual tumor detection rate at second look transurethral resection by 59%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257651

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  28 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Photodynamic diagnostics of bladder tumors.

Authors:  Stefan Denzinger; Maximilian Burger
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

3.  Mechanisms of recurrence of Ta/T1 bladder cancer.

Authors:  Richard T Bryan; Stuart I Collins; Mark C Daykin; Maurice P Zeegers; K K Cheng; D Michael A Wallace; Graham M Sole
Journal:  Ann R Coll Surg Engl       Date:  2010-06-01       Impact factor: 1.891

4.  [Therapy of low-grade nonmuscle-invasive bladder cancer].

Authors:  P J Olbert; C H Ohlmann; C Schwentner
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

5.  Application of new technology in bladder cancer diagnosis and treatment.

Authors:  Alvin C Goh; Seth P Lerner
Journal:  World J Urol       Date:  2009-02-22       Impact factor: 4.226

6.  Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:  Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Journal:  Rev Urol       Date:  2008

7.  Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results?

Authors:  Wolfgang Otto; Maximilian Burger; Hans-Martin Fritsche; Andreas Blana; Wolfgang Roessler; Ruth Knuechel; Wolf F Wieland; Stefan Denzinger
Journal:  Clin Med Oncol       Date:  2009-04-30

8.  [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study].

Authors:  T Filbeck; U Pichlmeier; R Knuechel; W F Wieland; W Rössler
Journal:  Urologe A       Date:  2003-04-25       Impact factor: 0.639

9.  Value of fluorescence cystoscopy in high risk non-muscle invasive bladder cancer.

Authors:  Roman Mayr; Maximilian Burger
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

Review 10.  [Fluorescence cystoscopy at bladder cancer: present trials].

Authors:  D Zaak; A Karl; H Stepp; S Tritschler; D Tilki; M Burger; R Knuechel; C Stief
Journal:  Urologe A       Date:  2007-11       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.